Skip to content
Skip to navigation
Fresh perspectives from some of the best minds in the business
The Pivot: Serology testing to track patients' exposure to SARS-CoV-2
The challenges of returning to work after the COVID-19 confinement
The Pivot: When can Canadians expect a vaccine for COVID-19?
The Pivot: Repurposing old drugs for COVID-19 treatment
New realities. How can pharma adapt to COVID-19 needs?
Advocacy is not on pause—time to pick up the phone!
Public Affairs and Government Relations |
The Pivot: The importance of COVID-19 rapid testing systems
Yves-François Blanchet at the Ghislain Dufour Business Forum
Public Affairs and Government Relations
Cybersecurity in the time of COVID-19
Capital Markets |
Crisis and Issues Management
Manufacturing sector: Managing the post-traumatic shock of COVID-19 and bouncing back
The Ripple Effect of the COVID-19 pandemic on clinical trials
Communicating with vulnerable populations during a health crisis
Meet Canada’s storytellers
Our team at NATIONAL is almost 300 strong, and every one of us has stories to tell